Über diese Folge
<p>In summer of 2019 NICE approved the use of a completely new class of drugs: the gene silencers. These compounds are transforming the lives of families who have rare debilitating – and sometimes fatal - diseases such as amyloidosis and porphyria. James Gallagher, BBC Health and Science Correspondent, reveals the ups and downs in the story of how a Nobel prize winning discovery of RNA interference has become a useful drug in less than a quarter of a century.</p><p>Professor Craig Mello, one of the winners of the Nobel Prize in 2006 for revealing the mechanism of RNA interference, and Professor Mark Kay of Stanford University, look back at the discovery.</p><p>Sue Burrell, who has acute intermittent porphyria, explains how a gene silencing drug has reversed her symptoms of extreme pain. Dr Carlos Heras-Palou, an orthopaedic surgeon at Royal Derby Hospital, who has hereditary transthyretin-mediated amyloidosis has had his career saved by taking another gene silencing drug, patisaran. It has restored the feeling in his hands he had lost and means that he can continue to carry out operations. Professor Philip Hawkins, of the National Amyloidosis Centre at the Royal Free Hospital, tells James about how his team showed that this drug reverses some of the symptoms caused by the disease.</p><p>As well as treating these rare conditions James discovers that this approach is being tried in untreatable neurodegenerative conditions. He talks to Professor Sarah Tabrizi of UCL about her research into stopping Huntington's disease, which is currently inevitably fatal.</p><p>Akshay Vaishnaw of the biotech company Alnylam talks to James about the ups and downs of developing effective RNAi drugs.</p><p>And Professor John Kastelein of Amsterdam University discusses the findings of a study into finding out if gene silencing could help prevent one of the biggest global killers; bad cholesterol that causes heart attacks and stroke.</p><p>Picture: DNA molecules, structure of the genetic code, 3d rendering,conceptual image, Credit: Andy/GettyImages</p>
Hör diese Folge auf Englisch, um Englisch zu lernen
Podcast-Folgen sind eine der dichtesten Möglichkeiten, Englisch im nativen Tempo aufzunehmen. The silence of the genes von Discovery bietet dir natürliche Dialoge, unvorbereitete Sprache und Vokabular, das wirklich in echten Gesprächen auftaucht.
In der Clue-App ist jedes Wort im Transkript antippbar. Tippe auf ein unbekanntes Wort, sieh die Übersetzung in deiner Sprache sofort und höre weiter, ohne aus dem Fluss zu kommen.
Folgen zum Englischlernen
- The friendly virus 22. Juni 2026
- The Life Scientific: Dean Lomax 15. Juni 2026
- The Life Scientific: Helen Hastie 8. Juni 2026
- The Life Scientific: Seth Berkley 1. Juni 2026
- The Life Scientific: Hiranya Peiris 25. Mai 2026
- The Life Scientific: Washington Yotto Ochieng 18. Mai 2026
- The Life Scientific: Lucy Carpenter 11. Mai 2026
- The Life Scientific: Jens Juul Holst 4. Mai 2026
- The Life Scientific: Jim Ashworth-Beaumont 27. Apr. 2026
- Inside Universe 25 20. Apr. 2026
- Dark Breath 13. Apr. 2026
- Superbugs: Resistance Rising Part 3 6. Apr. 2026
- Superbugs: Resistance rising, part 2 30. März 2026
- Superbugs: Resistance rising, part 1 23. März 2026
- The Life Scientific: Jehane Ragai 16. März 2026
- The Life Scientific: Tony Juniper 9. März 2026
- The Life Scientific: Pierre Friedlingstein 2. März 2026
- The Life Scientific: Julia Simner 23. Feb. 2026
- The Life Scientific: Caroline Smith 16. Feb. 2026
- The Life Scientific: AP De Silva 9. Feb. 2026
- The Life Scientific: Eleanor Schofield 2. Feb. 2026
- The Life Scientific: Peter Knight 26. Jan. 2026
- Frontiers of Earth Science 19. Jan. 2026
- Frontiers of Space Science 12. Jan. 2026
- What is Quantum? 5. Jan. 2026
- The Life Scientific: George Church 29. Dez. 2025
- The Life Scientific: Gareth Collett 22. Dez. 2025
- The Life Scientific: Sonia Gandhi 15. Dez. 2025
- The Life Scientific: Mark O'Shea 8. Dez. 2025
- Waking up with a different voice 1. Dez. 2025